These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27366815)

  • 1. Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease.
    Cardoso S; Seiça RM; Moreira PI
    Expert Rev Neurother; 2017 Jan; 17(1):77-91. PubMed ID: 27366815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.
    Bonda DJ; Wang X; Perry G; Smith MA; Zhu X
    Drugs Aging; 2010 Mar; 27(3):181-92. PubMed ID: 20210366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    Adiele RC; Adiele CA
    J Alzheimers Dis; 2016 Jul; 53(4):1257-70. PubMed ID: 27392851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
    Cadonic C; Sabbir MG; Albensi BC
    Mol Neurobiol; 2016 Nov; 53(9):6078-6090. PubMed ID: 26537901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!
    Cardoso SM; Correia SC; Carvalho C; Moreira PI
    Handb Exp Pharmacol; 2017; 240():281-308. PubMed ID: 28251365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mitochondrial defects and oxidative stress in Alzheimer's disease.
    Islam BU; Jabir NR; Tabrez S
    J Drug Target; 2019 Nov; 27(9):932-942. PubMed ID: 30775938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine.
    Cardoso S; Carvalho C; Correia SC; Seiça RM; Moreira PI
    Brain Pathol; 2016 Sep; 26(5):632-47. PubMed ID: 27327899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons.
    Reddy PH
    Antioxid Redox Signal; 2007 Oct; 9(10):1647-58. PubMed ID: 17696767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
    J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease.
    Monteiro-Cardoso VF; Oliveira MM; Melo T; Domingues MR; Moreira PI; Ferreiro E; Peixoto F; Videira RA
    J Alzheimers Dis; 2015; 43(4):1375-92. PubMed ID: 25182746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
    Grimm A; Friedland K; Eckert A
    Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Fang D; Swerdlow RH; Yu H; Chen JX; Yan SS
    J Alzheimers Dis; 2016 Sep; 54(2):679-90. PubMed ID: 27567872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction: A potential target for Alzheimer's disease intervention and treatment.
    Ke J; Tian Q; Xu Q; Fu Z; Fu Q
    Drug Discov Today; 2021 Aug; 26(8):1991-2002. PubMed ID: 33962036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial biology in Alzheimer's disease pathogenesis.
    Galindo MF; Ikuta I; Zhu X; Casadesus G; Jordán J
    J Neurochem; 2010 Aug; 114(4):933-45. PubMed ID: 20492350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.